LINC01876: A Potential Drug Target and Biomarker (G101929378)

Target Name: LINC01876

NCBI ID: G101929378

LINC01876

Other Name(s): Long intergenic non-protein coding RNA 1876, transcript variant 2 | long intergenic non-protein coding RNA 1876

LINC01876: A Potential Drug Target and Biomarker

LINC01876 is a long intergenic non-protein coding RNA (lncRNA) with a transcript variant of 2. It is a non-coding RNA molecule that has been identified using RNA-seq technology as highly expressed in various tissues and organs, including brain, heart, and muscle. Despite its non-protein nature, LINC01876 has been shown to play a role in the regulation of gene expression and has been associated with a number of diseases, including cancer and neurodegenerative diseases.

One of the key features of LINC01876 is its expression pattern. It is highly expressed in the brain and has been shown to be expressed in various neural cell types, including neurons and glial cells. It is also expressed in other tissues and organs, including heart and muscle. These findings suggest that LINC01876 may be involved in the regulation of neural development and function, and may be a potential drug target for treating neurodegenerative diseases.

In addition to its expression pattern, LINC01876 has also been shown to play a role in the regulation of gene expression in cancer cells. It has been shown to be highly expressed in a variety of cancer types, including lung, breast, and colon cancer. These findings suggest that LINC01876 may be a potential biomarker for cancer and may be a target for cancer therapies.

Another potential aspect of LINC01876 is its function as a non-protein coding RNA. While the function of LINC01876 is not yet fully understood, it is known that it can interact with protein molecules and regulate their activity. This suggests that LINC01876 may have a role in the regulation of cellular processes, including protein function and interactions.

Given the unique combination of expression patterns and functions, LINC01876 is an attractive candidate for further investigation as a potential drug target or biomarker. Further studies are needed to fully understand its role in neural development and function, as well as its potential role as a cancer biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 1876

The "LINC01876 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01876 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets